UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058920
Receipt number R000067386
Scientific Title An Exploratory Study on the Effects of Office-Based Exercise Interventions on Workers' Health Behaviors
Date of disclosure of the study information 2025/09/01
Last modified on 2025/08/28 18:43:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An Exploratory Study on the Effects of Office-Based Exercise Interventions on Workers' Health Behaviors

Acronym

An Exploratory Study of the Effects of Office Exercise Interventions

Scientific Title

An Exploratory Study on the Effects of Office-Based Exercise Interventions on Workers' Health Behaviors

Scientific Title:Acronym

An Exploratory Study of the Effects of Office Exercise Interventions

Region

Japan


Condition

Condition

Physical inactivity

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore the effects of an exercise intervention tailored for office workers (office-based exercise intervention) on the behavioral change stages of workers' exercise habits and on health behaviors.

Basic objectives2

Others

Basic objectives -Others

To explore the effects of an exercise intervention tailored for office workers (office-based exercise intervention) on the behavioral change stages of workers' exercise habits and on health behaviors.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Stages of behavioral change in exercise habits at baseline, at the end of the 3-month intervention, and 3 months after the end of the intervention

Key secondary outcomes

Pre-intervention (baseline), at the end of the 3-month intervention, and 3 months after the intervention ended:
-Daily step count
-Mets during work (light, moderate, vigorous, moderate-to-vigorous)
-Mets during daily life (light, moderate, vigorous, moderate-to-vigorous)
-Prolonged sedentary time during work
-Prolonged sedentary time during daily life
Subjective health assessment
-Self-reported symptoms: shoulder stiffness, lower back pain, body stiffness, eye fatigue, headache
-Japanese version of the Somatic Symptom Scale (SSS-8)
Mental health measures
-Non-specific stress indicator: Kessler 6-Item Psychological Distress Scale (K6)
Work engagement
-Japanese version of the Utrecht Work Engagement Scale
-Japanese version of the WHO Work and Work Performance Questionnaire
Qualitative analysis via group interviews
Barriers to health behaviors


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

ASPO inc. delivers interventions through a comprehensive program composed of its proprietary content. Each intervention session lasts approximately 15 minutes, with participants completing one exercise session per week over 12 weeks.

In-person program (specialized trainers visit corporate offices to provide instruction)
- Refresh exercises within the office
- Light resistance training within the office
- Health behavior awareness activities (workshop format)
- Physical fitness performance assessment
- Personalized guidance

Online Program (supplementary method when in-person sessions are not feasible)
- On-demand exercise content
- Real-time online refresh sessions (trainer-led)
- Online personal guidance
- Online health behavior awareness activities (workshop format)

Interventions/Control_2

The control group will not receive exercise instruction or related information during the intervention period.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

For individuals
- Individuals who are adults at the time consent is obtained
- Individuals who have provided consent to participate in the study

For clusters
- Clusters must be able to secure 25 participants within the same company prior to the start of the intervention.
- Intervention group clusters must be able to secure an environment (space, etc.) where office-based exercise can be conducted.

Key exclusion criteria

For individuals
- Individuals for whom exercise is contraindicated (discontinued by physician)
- Individuals unable to complete at least one-third of the exercise intervention due to extended business trips exceeding one month during the intervention period
- Pregnant women or those who may be pregnant
- Individuals unable to continue the exercise for any reason
- Other individuals deemed unsuitable by the principal investigator or co-investigators

For clusters
- Clusters cannot secure 25 participants within the same company prior to intervention commencement.
- Intervention group clusters cannot secure an environment (space, etc.) suitable for implementing office-based exercise programs.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Ken
Middle name
Last name Nakata

Organization

Graduate School of Medicine, The University of Osaka

Division name

Department of Health and Sport Sciences

Zip code

565-0871

Address

2-2 Yamadaoka, Suita, Osaka

TEL

06-6210-8439

Email

ogasawara.issei.med@osaka-u.ac.jp


Public contact

Name of contact person

1st name Issei
Middle name
Last name Ogasawara

Organization

Graduate School of Medicine, The University of Osaka

Division name

Department of Health and Sport Sciences

Zip code

565-0871

Address

2-2 Yamadaoka, Suita, Osaka

TEL

06-6210-8439

Homepage URL


Email

ogasawara.issei.med@osaka-u.ac.jp


Sponsor or person

Institute

The University of Osaka

Institute

Department

Personal name

Ken Nakata


Funding Source

Organization

Japan Sports Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The University of Osaka Hospital Ethical Review Board

Address

2-2 Yamadaoka, Suita, Osaka

Tel

06-6210-8296

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 08 Month 27 Day

Date of IRB


Anticipated trial start date

2025 Year 09 Month 08 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry

2027 Year 09 Month 30 Day

Date trial data considered complete

2027 Year 09 Month 30 Day

Date analysis concluded

2027 Year 12 Month 27 Day


Other

Other related information



Management information

Registered date

2025 Year 08 Month 28 Day

Last modified on

2025 Year 08 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067386